SEC Form 4 · accession 0000899243-15-010239
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Tomasi
Officer — See Remarks
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | D | 12,599 | $90.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (NQ) - 8/1/13 | $2.1284 | Dec 17, 2015 | D | 155,983 | D | Aug 1, 2014 | Jul 31, 2023 | Common Stock | 155,983 | 0 | D |
| Employee Stock Option (NQ) - 4/24/14 | $10.9242 | Dec 17, 2015 | D | 3,190 | D | Apr 24, 2015 | Apr 23, 2024 | Common Stock | 3,190 | 0 | D |
| Employee Stock Option (ISO) - 4/24/14 | $10.9242 | Dec 17, 2015 | D | 17,279 | D | Apr 24, 2015 | Apr 23, 2024 | Common Stock | 17,279 | 0 | D |
| Employee Stock Option (ISO) - 7/8/14 | $27.16 | Dec 17, 2015 | D | 4,095 | D | Jul 7, 2015 | Jul 6, 2024 | Common Stock | 4,095 | 0 | D |
| Employee Stock Option (NQ) - 7/8/14 | $27.16 | Dec 17, 2015 | D | 22,125 | D | Jul 7, 2015 | Jul 6, 2024 | Common Stock | 22,125 | 0 | D |
| Employee Stock Option (ISO) - 1/23/15 | $46.00 | Dec 17, 2015 | D | 99 | D | Jan 23, 2016 | Jan 22, 2025 | Common Stock | 99 | 0 | D |
| Employee Stock Option (NQ) - 1/23/15 | $46.00 | Dec 17, 2015 | D | 4,675 | D | Jan 23, 2016 | Jan 22, 2025 | Common Stock | 4,675 | 0 | D |
| Employee Stock Option (ISO) - 6/18/15 | $55.57 | Dec 17, 2015 | D | 1,717 | D | Jun 18, 2016 | Jun 17, 2025 | Common Stock | 1,717 | 0 | D |
| Employee Stock Option (NQ) - 6/18/15 | $55.57 | Dec 17, 2015 | D | 15,158 | D | Jun 18, 2016 | Jun 17, 2025 | Common Stock | 15,158 | 0 | D |
Explanation of responses
- F1Includes 3,000 shares in the form of restricted stock units and 443 shares acquired under the Employee Stock Purchase Plan on December 9, 2015
Remarks
Chief Scientific Officer and Head of Corporate Development